Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial.

Stensballe LG, Ravn H, Birk NM, Kjærgaard J, Nissen TN, Pihl GT, Thøstesen LM, Greisen G, Jeppesen DL, Kofoed PE, Pryds O, Sørup S, Aaby P, Benn CS.

J Pediatric Infect Dis Soc. 2018 Apr 7. doi: 10.1093/jpids/piy029. [Epub ahead of print]

PMID:
29635419
2.

Mothers' informational needs when deciding to have their newborn infant vaccinated with BCG. A Mixed-methods design.

Pihl GT, Ammentorp J, Johannessen H, Kjaergaard J, Nissen TN, Birk NM, Stensballe LG, Thøstesen LM, Kofoed PE.

Scand J Caring Sci. 2018 Sep;32(3):1118-1126. doi: 10.1111/scs.12557. Epub 2018 Jan 25.

PMID:
29369380
3.

Effects of Bacillus Calmette-Guérin (BCG) vaccination at birth on T and B lymphocyte subsets: Results from a clinical randomized trial.

Birk NM, Nissen TN, Kjærgaard J, Hartling HJ, Thøstesen LM, Kofoed PE, Stensballe LG, Andersen A, Pryds O, Netea MG, Benn CS, Nielsen SD, Jeppesen DL.

Sci Rep. 2017 Sep 29;7(1):12398. doi: 10.1038/s41598-017-11601-6.

4.

Neonatal BCG vaccination and atopic dermatitis before 13 months of age: A randomized clinical trial.

Thøstesen LM, Kjaergaard J, Pihl GT, Birk NM, Nissen TN, Aaby P, Jensen AKG, Olesen AW, Stensballe LG, Jeppesen DL, Benn CS, Kofoed PE.

Allergy. 2018 Feb;73(2):498-504. doi: 10.1111/all.13314. Epub 2017 Oct 9.

PMID:
28929567
5.

Bacillus Calmette-Guérin vaccination at birth and in vitro cytokine responses to non-specific stimulation. A randomized clinical trial.

Nissen TN, Birk NM, Blok BA, Arts RJW, Andersen A, Kjærgaard J, Thøstesen LM, Hoffmann T, Jeppesen DL, Nielsen SD, Kofoed PE, Stensballe LG, Aaby P, Ruhwald M, Netea MG, Benn CS, Pryds O.

Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):29-41. doi: 10.1007/s10096-017-3097-2. Epub 2017 Sep 10.

PMID:
28890996
6.

The association between Bacillus Calmette-Guérin vaccination (1331 SSI) skin reaction and subsequent scar development in infants.

Birk NM, Nissen TN, Ladekarl M, Zingmark V, Kjærgaard J, Jensen TM, Jensen SK, Thøstesen LM, Kofoed PE, Stensballe LG, Andersen A, Pryds O, Nielsen SD, Benn CS, Jeppesen DL.

BMC Infect Dis. 2017 Aug 3;17(1):540. doi: 10.1186/s12879-017-2641-0.

7.

Neonatal BCG has no effect on allergic sensitization and suspected food allergy until 13 months.

Thøstesen LM, Kjaer HF, Pihl GT, Nissen TN, Birk NM, Kjaergaard J, Jensen AKG, Aaby P, Olesen AW, Stensballe LG, Jeppesen DL, Benn CS, Kofoed PE.

Pediatr Allergy Immunol. 2017 Sep;28(6):588-596. doi: 10.1111/pai.12748.

PMID:
28660649
8.

The validity of register data to identify children with atopic dermatitis, asthma or allergic rhinoconjunctivitis.

Stensballe LG, Klansø L, Jensen A, Haerskjold A, Thomsen SF, Simonsen J.

Pediatr Allergy Immunol. 2017 Sep;28(6):535-542. doi: 10.1111/pai.12743. Epub 2017 Jul 27.

PMID:
28632331
9.

Neonatal BCG vaccination has no effect on recurrent wheeze in the first year of life: A randomized clinical trial.

Thøstesen LM, Stensballe LG, Pihl GT, Kjærgaard J, Birk NM, Nissen TN, Jensen AKG, Aaby P, Olesen AW, Jeppesen DL, Benn CS, Kofoed PE.

J Allergy Clin Immunol. 2017 Dec;140(6):1616-1621.e3. doi: 10.1016/j.jaci.2016.12.990. Epub 2017 Mar 25.

10.

Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial.

Nissen TN, Birk NM, Smits G, Jeppesen DL, Stensballe LG, Netea MG, van der Klis F, Benn CS, Pryds O; Calmette Study Group.

Vaccine. 2017 Apr 11;35(16):2084-2091. doi: 10.1016/j.vaccine.2017.02.048. Epub 2017 Mar 15.

11.

Palivizumab Exposure and the Risk of Atopic Dermatitis, Asthma and Allergic Rhinoconjunctivitis: A Cross-National, Population-Based Cohort Study.

Haerskjold A, Stokholm L, Linder M, Thomsen SF, Bergman G, Berglind IA, Kieler H, Ravn H, Stensballe LG.

Paediatr Drugs. 2017 Apr;19(2):155-164. doi: 10.1007/s40272-017-0215-7.

PMID:
28188494
12.

Does BCG have non-specific effects on childhood mortality?

Stensballe LG.

BMJ. 2017 Feb 10;356:j700. doi: 10.1136/bmj.j700. No abstract available.

PMID:
28188171
13.

Bacillus Calmette-Guérin vaccination, thymic size, and thymic output in healthy newborns.

Birk NM, Nissen TN, Zingmark V, Kjærgaard J, Thøstesen LM, Kofoed PE, Stensballe LG, Andersen A, Nielsen SD, Benn CS, Pryds O, Jeppesen DL.

Pediatr Res. 2017 Jun;81(6):873-880. doi: 10.1038/pr.2017.27. Epub 2017 Feb 3.

14.

Recruiting to Clinical Trials on the Telephone - a randomized controlled trial.

Foss KT, Kjærgaard J, Stensballe LG, Greisen G.

Trials. 2016 Nov 21;17(1):552.

15.

Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial.

Kjærgaard J, Birk NM, Nissen TN, Thøstesen LM, Pihl GT, Benn CS, Jeppesen DL, Pryds O, Kofoed PE, Aaby P, Greisen G, Stensballe LG.

Pediatr Res. 2016 Nov;80(5):681-685. doi: 10.1038/pr.2016.142. Epub 2016 Jul 18.

PMID:
27429204
16.

Palivizumab Exposure and the Risk of Autoimmune Disease: A Cross-National Cohort Study.

Haerskjold A, Linder M, Henriksen L, Thomsen SF, Kieler H, Ravn H, Stensballe LG.

Paediatr Drugs. 2016 Dec;18(6):435-441.

PMID:
27665287
17.

BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial.

Stensballe LG, Sørup S, Aaby P, Benn CS, Greisen G, Jeppesen DL, Birk NM, Kjærgaard J, Nissen TN, Pihl GT, Thøstesen LM, Kofoed PE, Pryds O, Ravn H.

Arch Dis Child. 2017 Mar;102(3):224-231. doi: 10.1136/archdischild-2016-310760. Epub 2016 Jul 21.

18.

Bacillus Calmette-Guérin vaccination at birth: Effects on infant growth. A randomized clinical trial.

Kjærgaard J, Stensballe LG, Birk NM, Nissen TN, Thøstesen LM, Pihl GT, Nielsen AV, Kofoed PE, Aaby P, Pryds O, Greisen G.

Early Hum Dev. 2016 Sep;100:49-54. doi: 10.1016/j.earlhumdev.2016.05.015. Epub 2016 Jul 7.

PMID:
27394195
19.

Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial.

Kjærgaard J, Stensballe LG, Birk NM, Nissen TN, Foss KT, Thøstesen LM, Pihl GT, Andersen A, Kofoed PE, Pryds O, Greisen G.

PLoS One. 2016 Apr 28;11(4):e0154541. doi: 10.1371/journal.pone.0154541. eCollection 2016.

20.

Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.

Nissen TN, Birk NM, Kjærgaard J, Thøstesen LM, Pihl GT, Hoffmann T, Jeppesen DL, Kofoed PE, Greisen G, Benn CS, Aaby P, Pryds O, Stensballe LG.

Vaccine. 2016 May 11;34(22):2477-82. doi: 10.1016/j.vaccine.2016.03.100. Epub 2016 Apr 7.

21.

Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark: Nationwide Retrospective Cohort Study.

Sørup S, Stensballe LG, Krause TG, Aaby P, Benn CS, Ravn H.

Open Forum Infect Dis. 2015 Dec 17;3(1):ofv204. doi: 10.1093/ofid/ofv204. eCollection 2016 Jan.

22.

The Danish National Prescription Registry in studies of a biological pharmaceutical: palivizumab - validation against two external data sources.

Haerskjold A, Henriksen L, Way S, Malham M, Hallas J, Pedersen L, Stensballe LG.

Clin Epidemiol. 2015 May 8;7:305-12. doi: 10.2147/CLEP.S73355. eCollection 2015.

23.

Bacillus Calmette-Guérin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trial.

Thøstesen LM, Nissen TN, Kjærgaard J, Pihl GT, Birk NM, Benn CS, Greisen G, Kofoed PE, Pryds O, Ravn H, Jeppesen DL, Aaby P, Stensballe LG.

Contemp Clin Trials. 2015 May;42:213-8. doi: 10.1016/j.cct.2015.04.006. Epub 2015 Apr 18.

24.

Erratum to: disappointment and adherence among parents of newborns allocated to the control group: a qualitative study of a randomized clinical trial.

Petersen SM, Zoffmann V, Kjærgaard J, Stensballe LG, Greisen G.

Trials. 2015 Mar 14;16:93. doi: 10.1186/s13063-015-0616-2. No abstract available.

25.

Incidence rates of atopic dermatitis, asthma, and allergic rhinoconjunctivitis in Danish and Swedish children.

Henriksen L, Simonsen J, Haerskjold A, Linder M, Kieler H, Thomsen SF, Stensballe LG.

J Allergy Clin Immunol. 2015 Aug;136(2):360-6.e2. doi: 10.1016/j.jaci.2015.02.003. Epub 2015 Mar 29.

PMID:
25828267
26.

Children with hemodynamically significant congenital heart disease can be identified through population-based registers.

Bergman G, Hærskjold A, Stensballe LG, Kieler H, Linder M.

Clin Epidemiol. 2015 Jan 23;7:119-27. doi: 10.2147/CLEP.S73358. eCollection 2015.

27.

Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact.

Sørup S, Benn CS, Stensballe LG, Aaby P, Ravn H.

Vaccine. 2015 Jan 1;33(1):237-45. doi: 10.1016/j.vaccine.2014.07.110. Epub 2014 Nov 1.

28.

[The bacille Calmette-Guérin vaccine may reduce the general child morbidity].

Nissen TN, Thøstesen LM, Birk NM, Pihl G, Kjærgaard J, Stensballe LG.

Ugeskr Laeger. 2014 Apr 28;176(9). pii: V12120700. Review. Danish.

PMID:
25096560
29.

Gene-environment interaction in atopic diseases: a population-based twin study of early-life exposures.

Kahr N, Naeser V, Stensballe LG, Kyvik KO, Skytthe A, Backer V, Bønnelykke K, Thomsen SF.

Clin Respir J. 2015 Jan;9(1):79-86. doi: 10.1111/crj.12110. Epub 2014 Feb 24.

PMID:
24444295
30.

Apgar score is related to development of atopic dermatitis: cotwin control study.

Naeser V, Kahr N, Stensballe LG, Kyvik KO, Skytthe A, Backer V, Carson CG, Thomsen SF.

J Allergy (Cairo). 2013;2013:712090. doi: 10.1155/2013/712090. Epub 2013 Oct 9.

31.

Identification of important and potentially avoidable risk factors in a prospective audit study of neonatal deaths in a paediatric hospital in Vietnam.

Kruse AY, Phuong CN, Ho BT, Stensballe LG, Pedersen FK, Greisen G.

Acta Paediatr. 2014 Feb;103(2):139-44. doi: 10.1111/apa.12423. Epub 2013 Oct 31.

PMID:
24107121
32.

Prematurity, asphyxia and congenital malformations underrepresented among neonates in a tertiary pediatric hospital in Vietnam.

Kruse AY, Ho BT, Phuong CN, Stensballe LG, Greisen G, Pedersen FK.

BMC Pediatr. 2012 Dec 29;12:199. doi: 10.1186/1471-2431-12-199.

33.

Use of antibiotics during pregnancy increases the risk of asthma in early childhood.

Stensballe LG, Simonsen J, Jensen SM, Bønnelykke K, Bisgaard H.

J Pediatr. 2013 Apr;162(4):832-838.e3. doi: 10.1016/j.jpeds.2012.09.049. Epub 2012 Nov 6.

PMID:
23140881
34.

Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study.

Kristensen K, Hjuler T, Ravn H, Simões EA, Stensballe LG.

Clin Infect Dis. 2012 Mar;54(6):810-7. doi: 10.1093/cid/cir928. Epub 2012 Jan 12.

PMID:
22247121
35.

Causal direction between respiratory syncytial virus bronchiolitis and asthma studied in monozygotic twins.

Poorisrisak P, Halkjaer LB, Thomsen SF, Stensballe LG, Kyvik KO, Skytthe A, Schioetz PO, Bisgaard H.

Chest. 2010 Aug;138(2):338-44. doi: 10.1378/chest.10-0365. Epub 2010 Apr 30.

PMID:
20435661
36.

Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age.

Stensballe LG, Fullarton JR, Carbonell-Estrany X, Simões EA.

Pediatr Infect Dis J. 2010 Apr;29(4):374-6. doi: 10.1097/INF.0b013e3181c810da.

PMID:
20016397
37.

Birth weight and risk of asthma in 3-9-year-old twins: exploring the fetal origins hypothesis.

Kindlund K, Thomsen SF, Stensballe LG, Skytthe A, Kyvik KO, Backer V, Bisgaard H.

Thorax. 2010 Feb;65(2):146-9. doi: 10.1136/thx.2009.117101. Epub 2009 Dec 8.

PMID:
19996338
38.

Risk factors for respiratory syncytial virus hospitalisation in children with heart disease.

Kristensen K, Stensballe LG, Bjerre J, Roth D, Fisker N, Kongstad T, Svendsen AL, Nielsen BW.

Arch Dis Child. 2009 Oct;94(10):785-9. doi: 10.1136/adc.2008.143057. Epub 2009 Jun 18.

PMID:
19541682
39.

Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study.

Thomsen SF, van der Sluis S, Stensballe LG, Posthuma D, Skytthe A, Kyvik KO, Duffy DL, Backer V, Bisgaard H.

Am J Respir Crit Care Med. 2009 Jun 15;179(12):1091-7. doi: 10.1164/rccm.200809-1471OC. Epub 2009 Mar 12.

PMID:
19286626
40.

Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus.

Stensballe LG, Ravn H, Kristensen K, Meakins T, Aaby P, Simoes EA.

J Pediatr. 2009 Feb;154(2):296-8. doi: 10.1016/j.jpeds.2008.07.053.

PMID:
19150677
41.

The causal direction in the association between respiratory syncytial virus hospitalization and asthma.

Stensballe LG, Simonsen JB, Thomsen SF, Larsen AM, Lysdal SH, Aaby P, Kyvik KO, Skytthe A, Backer V, Bisgaard H.

J Allergy Clin Immunol. 2009 Jan;123(1):131-137.e1. doi: 10.1016/j.jaci.2008.10.042.

PMID:
19130934
42.

Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze.

Stensballe LG, Ravn H, Kristensen K, Agerskov K, Meakins T, Aaby P, Simões EA.

J Allergy Clin Immunol. 2009 Feb;123(2):398-403. doi: 10.1016/j.jaci.2008.10.043. Epub 2008 Dec 19.

PMID:
19101023
43.

Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study.

Stensballe LG, Hjuler T, Andersen A, Kaltoft M, Ravn H, Aaby P, Simoes EA.

Clin Infect Dis. 2008 Apr 15;46(8):1165-71. doi: 10.1086/529438.

PMID:
18444851
44.

Increased concordance of severe respiratory syncytial virus infection in identical twins.

Thomsen SF, Stensballe LG, Skytthe A, Kyvik KO, Backer V, Bisgaard H.

Pediatrics. 2008 Mar;121(3):493-6. doi: 10.1542/peds.2007-1889.

PMID:
18310197
45.

Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study.

Stensballe LG, Kristensen K, Simoes EA, Jensen H, Nielsen J, Benn CS, Aaby P; Danish RSV Data Network.

Pediatrics. 2006 Nov;118(5):e1360-8.

PMID:
17079537
46.

Long-term consequences of respiratory syncytial virus acute lower respiratory tract infection in early childhood in Guinea-bissau.

Poulsen A, Stensballe LG, Nielsen J, Benn CS, Balde A, Roth A, Lisse IM, Aaby P.

Pediatr Infect Dis J. 2006 Nov;25(11):1025-31.

PMID:
17072125
47.

Beneficial non-targeted effects of BCG--ethical implications for the coming introduction of new TB vaccines.

Roth AE, Stensballe LG, Garly ML, Aaby P.

Tuberculosis (Edinb). 2006 Nov;86(6):397-403. Epub 2006 Aug 8. Review.

PMID:
16901755
48.

Differential effects of risk factors on infant wheeze and atopic dermatitis emphasize a different etiology.

Linneberg A, Simonsen JB, Petersen J, Stensballe LG, Benn CS.

J Allergy Clin Immunol. 2006 Jan;117(1):184-9. Epub 2005 Dec 2.

PMID:
16387604
49.

Diagnosis coding in The Danish National Patient Registry for respiratory syncytial virus infections.

Stensballe LG, Kristensen K, Nielsen J, Aaby P.

Scand J Infect Dis. 2005;37(10):747-52.

PMID:
16191894
50.

Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study.

Stensballe LG, Nante E, Jensen IP, Kofoed PE, Poulsen A, Jensen H, Newport M, Marchant A, Aaby P.

Vaccine. 2005 Jan 26;23(10):1251-7.

PMID:
15652667

Supplemental Content

Loading ...
Support Center